METHOD OF TREATING APHASIAS Russian patent published in 2010 - IPC A61K38/11 A61P9/10 

FIELD: medicine.

SUBSTANCE: invention concerns medicine, neurology section and can find application in neurologic and neural rehabilitation clinic in treating the patients with aphasia. That is ensured by administration of acatinol memantin according to certain schedule with underlying logopedic lessons. Within the first week of therapy, the dose is 5 mg/day in the morning at mealtime. Within the second week, the dose is 10 mg/days, with 5 mg in the morning and in the evening. Within the third week, the dose is increased to 15 mg/days, with 10 mg in the morning and 5 mg in the evening. Within the fourth week, the dose is increased to 20 mg/days. And the maintenance dose makes 20 mg/days.

EFFECT: method provides effective treatment of apparent rough aphasia caused by disordered cerebral blood flow.

1 ex, 2 tbl